Navigation Links


Hypocalcemia in Medical News

Procter & Gamble Wins Patent Infringement Lawsuit for Osteoporosis Therapy Actonel

... patients with hypocalcemia, known hypersensitivity to any component of this product, or inability to stand or sit upright for at least 30 minutes. hypocalcemia and other disturbances of bone and mineral metabolism should be effectively treated before starting Actonel therapy. Actonel is not recommended for ...

Health Alliance Announces First Fracture Protection Program for Actonel(R) (risedronate sodium) Tablets

... patients with hypocalcemia, known hypersensitivity to any component of this product, or inability to stand or sit upright for at least 30 minutes. hypocalcemia and other disturbances of bone and mineral metabolism should be effectively treated before starting Actonel therapy. Actonel is not recommended for ...

FDA Approves New Once-a-Month Dose of Actonel for Postmenopausal Osteoporosis

... in patients with hypocalcemia, known hypersensitivity to any component of this product, or inability to stand or sit upright for at least 30 minutes. hypocalcemia and other disturbances of bone and mineral metabolism should be effectively treated before starting Actonel therapy. Actonel is not recommended for ...
Hypocalcemia in Medical Technology

First Osteoporosis Study in Hip Fracture Patients Finds Once-Yearly Reclast(R) Prevents Additional Fractures and Improves Survival

... certain oncology indications. Reclast is contraindicated in patients with hypocalcemia (low blood calcium) and those who are allergic to zoledronic acid. Reclast ... by the prescriber prior to initiation of bisphosphonate treatment. hypocalcemia may occur with Reclast therapy. All patients with Paget's disease should ...

Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis

... certain oncology indications. Reclast is contraindicated in patients with hypocalcemia (low blood calcium) and those who are allergic to zoledronic acid. Reclast ... by the prescriber prior to initiation of bisphosphonate treatment. hypocalcemia may occur with Reclast therapy. In the Pivotal Fracture Trial an increased ...

New Phase III Data Presented for Once Monthly Dosing Regimen of Risedronate to Treat Postmenopausal Osteoporosis

... in patients with hypocalcemia, known hypersensitivity to any component of this product, or inability to stand or sit upright for at least 30 minutes. hypocalcemia and other disturbances of bone and mineral metabolism should be effectively treated before starting Actonel therapy. Actonel is not recommended for ...

ERBITUX(R) Meets Primary Endpoint of Increasing Survival in Phase III Lung Cancer Study

... cases, intravenous replacement was required. Patients receiving ERBITUX therapy should be periodically monitored for hypomagnesemia, and accompanying hypocalcemia and hypokalemia during, and up to 8 weeks following the completion of, ERBITUX therapy. The most serious adverse reactions associated with ERBITUX ...

Once-yearly Reclast Significantly Reduced Bone Fractures in Women with Postmenopausal Osteoporosis

... osteoporosis. Reclast is contraindicated in patients with hypocalcemia (low blood calcium), hypersensitivity to zoledronic acid and in women who ... already being treated with Zometa should not be treated with Reclast. hypocalcemia may occur with Reclast therapy. All patients with Paget's disease should ...

Survival Data Available from Erbitux Study in First-Line Treatment of Advanced Head and Neck Cancer

... intravenous replacement was required. Patients receiving ERBITUX therapy should be periodically monitored for hypomagnesemia, and accompanying hypocalcemia and hypokalemia during, and up to 8 weeks following the completion of, ERBITUX therapy. The most serious adverse reactions associated with ERBITUX ...

Survival Data Available From Erbitux Study in First-Line Treatment of Advanced Head and Neck Cancer

... intravenous replacement was required. Patients receiving ERBITUX therapy should be periodically monitored for hypomagnesemia, and accompanying hypocalcemia and hypokalemia during, and up to 8 weeks following the completion of, ERBITUX therapy. The most serious adverse reactions associated with ERBITUX ...

Data Available from Erbitux Phase III Study in First-Line Treatment of Advanced Pancreatic Cancer

... intravenous replacement was required. Patients receiving ERBITUX therapy should be periodically monitored for hypomagnesemia, and accompanying hypocalcemia and hypokalemia during, and up to 8 weeks following the completion of, ERBITUX therapy. The most serious adverse reactions associated with ERBITUX ...

Randomized Phase III Trial Showed Erbitux Significantly Improved Secondary Endpoints of Progression-Free Survival and Disease Control in Metastatic Colorectal Cancer Patients

... intravenous replacement was required. Patients receiving ERBITUX therapy should be periodically monitored for hypomagnesemia, and accompanying hypocalcemia and hypokalemia during, and up to 8 weeks following the completion of, ERBITUX therapy. The most serious adverse reactions associated with ERBITUX ...

Phase 2 Clinical Results of Ganite Plus Standard Therapy in Patients with Relapsed/Refractory Lymphoma Presented at ASCO

... Grade 4 lymphopenia, neutropenia and thrombocytopenia were observed in 1, 2 and 2 patients, respectively. Grade 1-3 anemia, nausea/vomiting and hypocalcemia were observed in 18, 1, and 3 patients, respectively. “Myelosuppression, particularly neutropenia, is a substantial clinical problem in ...

More>>

Hypocalcemia in Medical Products

MM-PTH RIA Test

Description:... hormone (PTH) is synthesized by the parathyroid glands [1,2] and secreted in response to decreased extracellular calcium concentrations. PTH prevents hypocalcemia by enhancing bone resorption and decreasing calcium excretion by the kidney. Following release into the circulation, intact PTH is rapidly degraded ...
Company:Diagnostic Systems Laboratories, Inc.

C-PTH RIA Test

Description:... hormone (PTH) is synthesized by the parathyroid glands [1,2] and secreted in response to decreased extracellular calcium concentrations. PTH prevents hypocalcemia by enhancing bone resorption and decreasing calcium excretion by the kidney. Following release into the circulation, intact PTH is rapidly degraded ...
Company:Diagnostic Systems Laboratories, Inc.

I-PTH IRMA Test

Description:... hormone (PTH) is synthesized by the parathyroid glands [1,2] and secreted in response to decreased extracellular calcium concentrations. PTH prevents hypocalcemia by enhancing bone resorption and decreasing calcium excretion by the kidney. Following release into the circulation, intact PTH is rapidly degraded ...
Company:Diagnostic Systems Laboratories, Inc.

I-PTH ELISA Test

Description:... hormone (PTH) is synthesized by the parathyroid glands [1,2] and secreted in response to decreased extracellular calcium concentrations. PTH prevents hypocalcemia by enhancing bone resorption and decreasing calcium excretion by the kidney. Following release into the circulation, intact PTH is rapidly degraded ...
Company:Diagnostic Systems Laboratories, Inc.
Hypocalcemia in Medical Dictionary

Hypocalcemia

... hypocalcemia is a condition in which there is too little calcium in the blood . A common form of hypocalcemia in babies is called neonatal hypocalcemia . This condition may occur at different times ...

Hyperventilation

... - Spasm s of the hands or feet that may be seen in association with hypocalcemia or hyperventilation . [ Med Help International ] [ Search ] [ Ask the ... medications used to treat diabetes . Hyperventilation syndrome hypocalcemia Hypoglycemia , insulin -reaction * - Hypothermia Hypothyroidism ...

Calcium

... disorders (that is, disease s of the para thyroid gland or kidney s). Calcium deficiency : A low level of calcium in the blood ( hypocalcemia ) which can make the nervous system highly irritable causing tetany ( spasm s of the hands and feet, muscle cramps , abdominal cramps , and ...

Calcium phosphate

... and coma , while prolonged and moderate hypercalcemia results in the deposit of calcium phosphate crystals in the kidney s and eye . hypocalcemia occurs when serum free calcium ions fall below 4. Bone: Bone is the substance that forms the skeleton of the body. It is composed chiefly ...

Dextrose

... ). ARTICLE TOOLS Print ... hypoglycemia - low blood sugar ; usually treated with IV fluids containing dextrose (another form of sugar ). hypocalcemia - low calcium levels in the blood ; usually treated with calcium in IV fluids. The body makes glucose from protein s, fats and, in ...

Hypercalcemia

... disorder of iron overload ( hemochromatosis ) or excessive blood levels of calcium ( hypercalcemia ). When blood calcium levels fall ( hypocalcemia ), calcium is released from bones to restore proper blood levels. When blood calcium levels rise ( hypercalcemia ), the excess calcium may ...

Hypoglycemia

... to store sugar instead of burning the sugar for energy. This causes too little sugar in the blood , a condition called hypoglycemia . hypocalcemia Hypoglycemia , insulin -reaction * - Hypothermia Hypothyroidism - diagnosis and treatment - diagnosis and treatment , brief ...

Low blood sugar

... large internal organ s, and defects of the abdominal wall near the navel. Hypo-: Prefix meaning "low, under, beneath, down, below normal" as in hypocalcemia (low calcium in the blood ), hypoglycemia ( low blood sugar ) and hyposensitivity. The opposite of hypo- is hyper-. See also: Sub-. ...

Pedal

... CARPO PEDAL SPASM - Spasm s of the hands or feet that may be seen in association with hypocalcemia or hyperventilation . [ Med Help International ] [ Search ] [ Ask the Doctor Forums ] ... Alternate Names : Carpo pedal Spasm , Foot Spasm s, ...

Tetany

... of an abnormality in calcium level, which can be linked to the following: ... Calcium deficiency : A low level of calcium in the blood ( hypocalcemia ) which can make the nervous system highly irritable causing tetany ( spasm s of the hands and feet, muscle cramps , abdominal cramps , and ...

More>>

Hypocalcemia in Biological Technology

FDA Approves New SPRYCEL(R) (Dasatinib) Product Labeling for Patients with Chronic-Phase CML

... The frequency of Grade 3/4 hypophosphatemia and hypocalcemia was 8% and 2%, respectively, in the SPRYCEL 100 ... in the Gleevec group. The frequency of Grade 3/4 hypocalcemia was 4% in the SPRYCEL group and 0% in the Gleevec ... or interruption. Patients developing Grade 3/4 hypocalcemia during the course of SPRYCEL therapy often had ...

Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis

... certain oncology indications. Reclast is contraindicated in patients with hypocalcemia (low blood calcium) and those who are allergic to zoledronic acid. Reclast ... by the prescriber prior to initiation of bisphosphonate treatment. hypocalcemia may occur with Reclast therapy. In the Pivotal Fracture Trial an increased ...

Lilly to Acquire ImClone Systems in $6.5 Billion Transaction

... electrolyte abnormalities occurred days to months after initiation of ERBITUX therapy - Monitor patients periodically for hypomagnesemia, hypocalcemia and hypokalemia, during, and for at least 8 weeks following the completion of, ERBITUX therapy - Replete electrolytes as necessary Late ...

Fontus Pharmaceuticals Acquires Nephrology and Endocrinology Drug from Roche Laboratories Inc.

... and resultant metabolic bone disease in patients with moderate to severe chronic renal failure (CRF) and by endocrinologists for the management of hypocalcemia in patients with post-surgical hypoparathyroidism, idiopathic hypoparathyroidism and pseudohypoparathyroidism. About ROCALTROL(R) (calcitriol) ...
Other Contentsassociationassociationassociationassociationassociationassociationassociationassociationlibrarieslibrarieslibrarieslibrarieslibrarieswrappingwrappingwrappingwrappingtolerancetolerancetolerancetolerancetolerancetolerancetoleranceinducedinducedinducedinducedinducedinducedinducedinducedinducedinducedmarginmarginmarginmarginmarginmarginmargin
(Date:12/1/2009)...lled clinical trial presented today at the annual ...ca (RSNA) reveal that one in five patients with na...to the legs and other parts of the body also have ..., Peripheral arterial disease (PAD) occurs when p... substances, builds up in the arteries, limiting t...
(Date:12/1/2009)...on-related injuries and deaths in the U.S. finds t...hospitals with aviation-related injuries annually,... study, conducted by researchers from the Johns Ho...or Injury Research and Policy and Columbia Univers...atients were occupants of civilian, noncommercial ...
(Date:11/30/2009)...- Results of a randomized, controlled clinical tri...diological Society of North America (RSNA) reveal ...ge in arteries that supply blood to the legs and o...ilent coronary artery disease. ,, Peripheral a...ation of fat, cholesterol and other substances, bu...
(Date:11/30/2009)...- Low-dose radiation from annual mammography scree... genetic or familial predisposition to breast canc...nual meeting of the Radiological Society of North ... breast cancer, screening is very important, but a... mammography for screening young women, particular...
(Date:11/30/2009)...swire-FirstCall/ -- VitaminSpice (OTC Bulletin Boa... "Bill" R. Fields to the Board of Directors. ,,...ersource Co. Ltd. Mr. Fields is a Director of Lexm...ved as Chairman and Chief Executive Officer of Fac... and Chief Executive Officer of Hudson,s Bay Compa...
Breaking Medicine News(10 mins):Health News:Severe asymptomatic heart disease may accompany narrowing in leg arteries 2Health News:More than 1,000 patients in US admitted annually for aviation-related injuries 2Health News:Severe Asymptomatic Heart Disease May Accompany Narrowing in Leg Arteries 2Health News:Severe Asymptomatic Heart Disease May Accompany Narrowing in Leg Arteries 3Health News:Mammography May Increase Breast Cancer Risk in Some High-Risk Women 2Health News:Mammography May Increase Breast Cancer Risk in Some High-Risk Women 3Health News:VitaminSpice Elects Bill Fields to the Board of Directors 2
(Date:11/30/2009)... organisation is needed to monitor the commitments...nhagen to cut their deforestation rates, according...ing government agencies and research groups have f...te images of the Earth,s surface collected each we... published by Dr Alan Grainger in the Proceedings...
(Date:11/30/2009)...ists from The Forsyth Institute, the University of...rth Center, have used state-of-the-art technology ...ma pallidum, the bacterium which causes syphilis. ...acteria can now be shown in three dimensions. This... reveals previously unknown features, which may he...
(Date:11/30/2009)..., 2009) Scientists and engineers from two of the ...will come together Dec. 7 with leading academician...ng blood. , Much like moving oil through a pipel...Both systems need clean, well-functioning pipes (o...to function efficiently. Both industries also are ...
Breaking Biology News(10 mins):World forest observatory needed to monitor vital role of forests in climate deal 2Scientists gain new understanding of disease-causing bacteria 2Similarities of pumping blood and oil examined 2Similarities of pumping blood and oil examined 3Tapping Into Currys Health Benefits 61342 1FDA Statement on Vibrio Vulnificus in Raw Oysters 61337 1FDA Statement on Vibrio Vulnificus in Raw Oysters 61337 2FDA Statement on Vibrio Vulnificus in Raw Oysters 61337 3Human Pheromone Sciences Announces Third Quarter Results 61332 1Human Pheromone Sciences Announces Third Quarter Results 61332 2Human Pheromone Sciences Announces Third Quarter Results 61332 3Human Pheromone Sciences Announces Third Quarter Results 61332 4
Other TagsHartmanOther Tagssuddenly 2suddenly 3suddenly 4urge 2beauty 2